Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02207907 · ClinicalTrials.gov registry record · Phase 2
To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 247
- Enrollment target
NCT02207907 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 247 participants.
The verdict
NCT02207907, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 247 participants
- Enrollment target
Study Summary
The primary objectives of this study will be to compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothpaste after 24 weeks of use. The study will be conducted at Silverstone Research Group. Participants will be recruited from their database and by use of an external recruitment agency.
Interventions
- DRUG Sodium fluoride
- DRUG Sodium bicarbonate plus sodium fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02207907
The ClinicalTrials.gov registry entry for NCT02207907 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium fluoride is the first listed.
NCT02207907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02207907 about?
NCT02207907 is a clinical study titled "To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste". The primary objectives of this study will be to compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothpaste after 24 weeks of use. The study will be conducted at Silverstone Research ...
What is the current status of trial NCT02207907?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 247 participants. The study started on 2014-08. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02207907?
The interventions under investigation include: Sodium fluoride (DRUG), Sodium bicarbonate plus sodium fluoride (DRUG).
Who is sponsoring clinical trial NCT02207907?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.